Prokineticin-2 is highly expressed in colonic mucosa of early Parkinson’s disease patients
Objective: To investigate the expression of PK2 in colonic biopsies of PD patients. Background: Neuroinflammation is emerging as a key factor involved in the pathophysiology…Women with Parkinson’s disease: exploring the occurrence of hormone-related symptom fluctuations and associated care
Objective: To explore the occurrence of hormone-related symptom fluctuations and associated care in women with Parkinson’s disease (PD). Background: Pre- and (peri)menopausal women with PD…The “Cat Killer’s Disease”: Lived Experience of Parkinson’s disease Patients in Ethiopia
Objective: The main objective of this study is to explore the lived experience of PD patients in Addis Ababa, Ethiopia. Background: Parkinson's disease (PD) is…Movement Disorders Knowledge Among Medical Professionals in Central Asia
Objective: To evaluate and recognize the knowledge of movement disorders among medical professionals in Central Asia. Background: The field of movement disorders encompasses a diverse…Beyond Memory:A Brain Health Awareness Kit for Spanish-speaking Communities
Objective: To develop an interactive workshop in Spanish that provides basic information about brain health and its importance so that community members can identify risk…Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review
Objective: To synthesize published literature about patient-reported symptoms (PRS) or changes from normal in prodromal and early motor stages of Parkinson’s disease (PD) and develop…Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention
Objective: To determine whether a Parkinson’s disease (PD) Inpatient Program will prevent medication errors and ultimately improve the safety and quality of care for hospitalized…Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?
Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…Pharmacokinetics And Safety Of YA-101, A Dual Inhibitors Of D-Amino Acid Oxidase (DAAO) And NLRP3 Inflammasome, In Healthy Subjects: A Double-Blind, Placebo-Controlled, Randomized, Single Dose and Multiple Dose Phase I Study
Objective: To evaluate the safety, tolerability, and pharmacokinetics (PK) profile of YA-101 in healthy volunteers with single dose and multiple dose Background: Multiple System Atrophy…Combining alpha-synuclein PET and seeded amplification assays to improve the diagnostic accuracy of Multiple System Atrophy of the Parkinsonian subtype (MSA-P)
Objective: To determine whether the combination of spatial (PET [18F]ACI-12589) and conformational (skin seed amplification assay; SAA) a-syn data aids the early differential diagnosis of…
- « Previous Page
- 1
- …
- 166
- 167
- 168
- 169
- 170
- …
- 181
- Next Page »